Cargando…
Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I)...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003283/ https://www.ncbi.nlm.nih.gov/pubmed/21188063 http://dx.doi.org/10.4103/0972-3919.72686 |
_version_ | 1782193852072853504 |
---|---|
author | Ravichandran, R Binukumar, JP Saadi, Amal Al |
author_facet | Ravichandran, R Binukumar, JP Saadi, Amal Al |
author_sort | Ravichandran, R |
collection | PubMed |
description | BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I) with activities above 400 MBq. MATERIALS & METHODS: A study of body burden estimation from sequentially measured exposure rates from patients treated for carcinoma thyroid and hyperthyroidism was undertaken. A digital auto-ranging beta gamma survey instrument calibrated for measurement of exposure rates is used in this study. RESULTS: The mean measured exposure rates at 1 m in μSv/h immediately after administration and at 24 h intervals are used for estimation of effective half time of clearance of administered activity. For patients with post-operative thyroid carcinoma, the variation of body burden with time post-administration indicated tri-exponential clearance pattern, with T(½eff) values 14.4 h, 22 h, and 41.3 h. For patients treated for thyrotoxicosis, the body burden showed slow delayed clearance with a T(½eff) – 111.4 h, and exposure rates did not show appreciable fall off after 48 h. |
format | Text |
id | pubmed-3003283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30032832010-12-23 Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid Ravichandran, R Binukumar, JP Saadi, Amal Al Indian J Nucl Med Original Article BACKGROUND: In medical applications of radioisotopes, for calculations of whole body doses and radiation safety applications, there is a need to estimate radioactive body burden. Local recommendations in Oman stipulate the need for hospitalization of patients treated for radioactive-iodine ((131) I) with activities above 400 MBq. MATERIALS & METHODS: A study of body burden estimation from sequentially measured exposure rates from patients treated for carcinoma thyroid and hyperthyroidism was undertaken. A digital auto-ranging beta gamma survey instrument calibrated for measurement of exposure rates is used in this study. RESULTS: The mean measured exposure rates at 1 m in μSv/h immediately after administration and at 24 h intervals are used for estimation of effective half time of clearance of administered activity. For patients with post-operative thyroid carcinoma, the variation of body burden with time post-administration indicated tri-exponential clearance pattern, with T(½eff) values 14.4 h, 22 h, and 41.3 h. For patients treated for thyrotoxicosis, the body burden showed slow delayed clearance with a T(½eff) – 111.4 h, and exposure rates did not show appreciable fall off after 48 h. Medknow Publications 2010 /pmc/articles/PMC3003283/ /pubmed/21188063 http://dx.doi.org/10.4103/0972-3919.72686 Text en © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ravichandran, R Binukumar, JP Saadi, Amal Al Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title | Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title_full | Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title_fullStr | Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title_full_unstemmed | Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title_short | Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid |
title_sort | estimation of effective half life of clearance of radioactive iodine ((131)i) in patients treated for hyperthyroidism and carcinoma thyroid |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003283/ https://www.ncbi.nlm.nih.gov/pubmed/21188063 http://dx.doi.org/10.4103/0972-3919.72686 |
work_keys_str_mv | AT ravichandranr estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid AT binukumarjp estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid AT saadiamalal estimationofeffectivehalflifeofclearanceofradioactiveiodine131iinpatientstreatedforhyperthyroidismandcarcinomathyroid |